A Diagnostics & Imaging Week
SPO Medical (Woodland Hills, California), a developer of biosensor and microprocessor technologies for use in portable monitoring devices, reported completing its reverse acquisition of United Diagnostic and is now listed under the symbol SPOM.PK.
SPO Medical develops pulse oximetry technology, an optical technique that enables the continuous measurement of blood oxygen saturation and heart rate. The company's technology is based on reflectance pulse oximetry, which it said enables it to develop affordable, portable devices using very small sensors that require a fraction of the power of currently available commercial systems.
Product applications are for professional and consumer products within four markets: medical care, home and remote care, sports and wellness, and safety and security.
"Becoming a publicly traded company is an important milestone for SPO Medical," said CEO Michael Braunold.